Literature DB >> 22627666

The Kunitz 1 and Kunitz 3 domains of tissue factor pathway inhibitor are required for efficient inhibition of factor Xa.

Sameera Peraramelli1, Dennis P L Suylen, Jan Rosing, Tilman M Hackeng.   

Abstract

Tissue factor pathway inhibitor (TFPI) is a slow tight-binding inhibitor that inhibits factor (F)Xa in a biphasic fashion: a rapid formation of loose FXa·TFPI encounter complex is followed by slow rearrangement into a tight FXa·TFPI* complex in which the Kunitz-2 (K2) domain of TFPI binds and inhibits FXa. In the current study, full-length TFPI (TFPIfl) and various truncated TFPI constructs were used to assess the importance of TFPI domains other than K2 in the inhibition of FXa. In the absence of Ca2+ ions, FXa was more effectively inhibited by TFPIfl than Gla-domain less FXa. In turn, Ca2+ ions impaired FXa inhibition by TFPIfl but not by TFPI constructs that lack the C-terminus. This suggests that, in absence of Ca2+ ions, interactions between the C-terminus of TFPI and the Gla-domain of FXa promote FXa-inhibition. TFPIfl and K2K3 had similar efficiencies for encounter complex formation. However, K2K3 showed monophasic inhibition instead of biphasic inhibition, indicating absence of rearrangement into a tight complex. K1K2 and TFPI1-161 showed biphasic inhibition, but had less efficient encounter complex formation than TFPIfl. Finally, K2K3 was a 10-fold more efficient FXa- inhibitor than K2. These results indicate that K3-C-terminus enhances the formation of encounter complex and that K1 is required for isomerisation of the encounter- into tight complex. Since TFPIfl has a 10-fold higher Ki than K2K3-C-terminus, we propose that K1 is not only required for the transition of the loose to the tight FXa·TFPI* complex, but also inhibits FXa·TFPI encounter complex formation. This inhibitory activity is counteracted by K3 and C-terminus.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22627666     DOI: 10.1160/TH11-12-0902

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  NMR structure determination of Ixolaris and factor X(a) interaction reveals a noncanonical mechanism of Kunitz inhibition.

Authors:  Viviane S De Paula; Nikolaos G Sgourakis; Ivo M B Francischetti; Fabio C L Almeida; Robson Q Monteiro; Ana Paula Valente
Journal:  Blood       Date:  2019-05-27       Impact factor: 22.113

2.  Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.

Authors:  T J Girard; K Grunz; N M Lasky; J P Malone; G J Broze
Journal:  J Thromb Haemost       Date:  2018-10-22       Impact factor: 5.824

Review 3.  Biology of tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

4.  Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI).

Authors:  Michael Dockal; Rudolf Hartmann; Markus Fries; M Christella L G D Thomassen; Alexandra Heinzmann; Hartmut Ehrlich; Jan Rosing; Frank Osterkamp; Thomas Polakowski; Ulrich Reineke; Andreas Griessner; Hans Brandstetter; Friedrich Scheiflinger
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

5.  Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use.

Authors:  Kristien Winckers; Stella Thomassen; Hugo Ten Cate; Tilman M Hackeng
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

6.  Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.

Authors:  Stella Thomassen; Tom G Mastenbroek; Frauke Swieringa; Kristien Winckers; Marion A H Feijge; Roy Schrijver; Judith M E M Cosemans; Susan A Maroney; Alan E Mast; Tilman M Hackeng; Johan W M Heemskerk
Journal:  Thromb Haemost       Date:  2018-02-16       Impact factor: 5.249

7.  The contribution of TFPIα to the hemostatic response to injury in mice.

Authors:  Tanya T Marar; Nicholas D Martinez; Susan A Maroney; Amy E Siebert; Jie Wu; Timothy J Stalker; Maurizio Tomaiuolo; Sinny Delacroix; Robert D Simari; Alan E Mast; Lawrence F Brass
Journal:  J Thromb Haemost       Date:  2021-07-14       Impact factor: 16.036

8.  Characterization of the enzymatic activity of the serine protease domain of Factor VII activating protease (FSAP).

Authors:  Nis V Nielsen; Elfie Roedel; Dipankar Manna; Michael Etscheid; Jens Preben Morth; Sandip M Kanse
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

Review 9.  The Composition and Physical Properties of Clots in COVID-19 Pathology.

Authors:  Sierk Dauwerse; Hugo Ten Cate; Henri M H Spronk; Magdolna Nagy
Journal:  Diagnostics (Basel)       Date:  2022-02-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.